All Formulary decision guide articles
View all stories of the same content type.
-
Formulary decision guideSoprobec (beclometasone dipropionate) pMDI
This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 V2 March 2021 -
Formulary decision guide
PROSTAP® DCS (leuprorelin acetate)
This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd. Information intended for healthcare professionals only.
View prescribing information here
C-APROM/UK/LEU/0075 February 2021 -
Formulary decision guide
Nutramigen* PURAMINO*
This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020 -
Formulary decision guide
Nutramigen* 1, 2 & 3 LGG®
This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020 -
Formulary decision guide
Formulary decision guide: Saxenda® (liraglutide injection 3 mg)
This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only.
Click here for the Prescribing Information and Adverse Events Reporting.
UK20SX00110
Date of preparation: October 2020
